SEC Form 4 · accession 0001576427-17-000091
Criteo S.A. · CRTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan Teodosiu
Officer — Chief Technical Officer
Period of report
May 5, 2017
Accepted (ET)
May 9, 2017 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576427
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | May 5, 2017 | M | 3,875 | $25.24 | A | 3,875 | D | |
| Ordinary SharesF1,F3 | May 5, 2017 | S | 3,875 | $52.00 | D | 0 | D | |
| Ordinary SharesF1,F4,F3 | May 5, 2017 | M | 1,875 | $38.68 | A | 1,875 | D | |
| Ordinary SharesF1,F3 | May 5, 2017 | S | 1,875 | $52.00 | D | 0 | D | |
| Ordinary SharesF1,F5,F3 | May 8, 2017 | M | 1,500 | $10.61 | A | 1,500 | D | |
| Ordinary SharesF1,F6,F3 | May 8, 2017 | S | 1,500 | $52.35 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2,F7,F1 | $25.24 | May 5, 2017 | M | 3,875 | D | — | Jul 30, 2024 | Ordinary Shares | 3,875 | 19,375 | D |
| Stock Option (right to buy)F3,F4,F8,F1 | $38.68 | May 5, 2017 | M | 1,875 | D | — | Oct 29, 2025 | Ordinary Shares | 1,875 | 18,750 | D |
| Employee Warrant (right to buy)F3,F5,F9,F1 | $10.61 | May 8, 2017 | M | 1,500 | D | — | Feb 7, 2023 | Ordinary Shares | 1,500 | 4,500 | D |
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2The exercise price of the stock option is 22.95 euros. The U.S. dollar equivalent of the exercise price is $25.24 using the Federal Reserve Bank of New York noon buying rate for May 5, 2017 (1.00 = $1.0996).
- F3For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").
- F4The exercise price of the stock option is 35.18 euros. The U.S. dollar equivalent of the exercise price is $38.68 using the Federal Reserve Bank of New York noon buying rate for May 5, 2017 (1.00 = $1.0996).
- F5The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.61 using the Federal Reserve Bank of New York noon buying rate for May 5, 2017 (1.00 = $1.0996)
- F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.30 to $52.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F7Stock option granted on July 30, 2014 under the Issuer's 2014 Stock Option Plan. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter, subject to continued service through each vesting date.
- F8Stock option granted on October 29, 2015 under the Issuer's 2014 Stock Option Plan. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter, subject to continued service through each vesting date.
- F9One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.